These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11576401)

  • 21. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris.
    Schrodt BJ; Kulp-Shorten CL; Callen JP
    South Med J; 1999 May; 92(5):502-4. PubMed ID: 10342897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.
    Gruber F; Grubisić-Greblo H; Kastelan M; Brajac I; Lenković M; Zamolo G
    J Chemother; 1998 Dec; 10(6):469-73. PubMed ID: 9876055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hypersensitivity reaction to minocycline.
    de Paz S; Pérez A; Gómez M; Trampal A; Domínguez Lázaro A
    J Investig Allergol Clin Immunol; 1999; 9(6):403-4. PubMed ID: 10664938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methyldopa reaction simulating septic shock.
    DeBard ML
    Arch Intern Med; 1979 Feb; 139(2):196-7. PubMed ID: 434973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline induced lupus: case series in the West of Scotland.
    Gordon MM; Porter D
    J Rheumatol; 2001 May; 28(5):1004-6. PubMed ID: 11361179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative safety of tetracycline, minocycline, and doxycycline.
    Shapiro LE; Knowles SR; Shear NH
    Arch Dermatol; 1997 Oct; 133(10):1224-30. PubMed ID: 9382560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapsing acute respiratory failure induced by minocycline.
    Oddo M; Liaudet L; Lepori M; Broccard AF; Schaller MD
    Chest; 2003 Jun; 123(6):2146-8. PubMed ID: 12796202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Minocycline-induced lupus erythematodes].
    Egger SS; Studer IG; Rätz Bravo AE; Krähenbühl S
    Praxis (Bern 1994); 2006 Aug; 95(35):1297-303. PubMed ID: 16970139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.
    Margolis DJ; Hoffstad O; Bilker W
    Br J Dermatol; 2007 Sep; 157(3):540-6. PubMed ID: 17596147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit-risk assessment of acne therapies.
    Seukeran DC; Eady EA; Cunliffe WJ
    Lancet; 1997 Apr; 349(9060):1251-2. PubMed ID: 9130967
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse Reactions Induced by Minocycline: A Review of Literature.
    Dominic MR
    Curr Drug Saf; 2021; 16(3):309-321. PubMed ID: 33494681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of acne vulgaris. A comparison of doxycycline versus minocycline].
    Laux B
    Hautarzt; 1989 Sep; 40(9):577-81. PubMed ID: 2530191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.
    Brown RJ; Rother KI; Artman H; Mercurio MG; Wang R; Looney RJ; Cowen EW
    Arch Dermatol; 2009 Jan; 145(1):63-6. PubMed ID: 19153345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute eosinophilic lung after a course of minocycline].
    Dussopt C; Mornex JF; Cordier JF; Brune J
    Rev Mal Respir; 1994; 11(1):67-70. PubMed ID: 8128099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of minocycline therapy for acne vulgaris: case reports and review of the literature.
    Somech R; Arav-Boger R; Assia A; Spirer Z; Jurgenson U
    Pediatr Dermatol; 1999; 16(6):469-72. PubMed ID: 10632948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral presentation of minocycline-induced black bone disease.
    Odell EW; Hodgson RP; Haskell R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Apr; 79(4):459-61. PubMed ID: 7614206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous pigmentation due to minocycline hydrochloride.
    Fenske NA; Millns JL
    J Am Acad Dermatol; 1980 Sep; 3(3):308-10. PubMed ID: 6450227
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythema nodosum leprosum associated with minocycline.
    Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies.
    Pelletier F; Puzenat E; Blanc D; Faivre B; Humbert P; Aubin F
    Eur J Dermatol; 2003; 13(4):396-8. PubMed ID: 12948923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.